Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary intervention

American Journal of Cardiology

Volumn 109, Issue 5, 2012, Pages 620-623

  Motovska, Zuzana ^a   Odvodyova, Denisa ^a   Fischerova, Michaela ^a   Stepankova, Sona ^b   Maly, Marek ^c   Morawska, Petra ^a   Widimsky, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; CYSTATIN C;

ADULT; AGED; ARTICLE; CORONARY STENT; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; STENT THROMBOSIS; VASODILATOR STIMULATED PHOSPHOPROTEIN INDEX;

EID: 84857637420     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.10.019     Document Type: Article

References (30)

1. P.A. McCullough Cardiorenal risk: an important clinical intersection Rev Cardiovasc Med 3 2002 71 76 (Pubitemid 34661885)
2. M.W. Yerkey, S.J. Kernis, B.A. Franklin, K.R. Sandberg, P.A. McCullough Renal dysfunction and acceleration of coronary disease Heart 90 2004 961 966 (Pubitemid 39005960)
3. J.W. van Werkum, A.A. Heestermans, A.C. Zomer, J.C. Kelder, M.J. Suttorp, B.J. Rensing, J.J. Koolen, B.R. Brueren, J.H. Dambrink, R.W. Hautvast, F.W. Verheugt, J.M. ten Berg Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
4. J. Aoki, A.J. Lansky, R. Mehran, J. Moses, M.E. Bertrand, B.T. McLaurin, D.A. Cox, A.M. Lincoff, E.M. Ohman, H.D. White, H. Parise, M.B. Leon, G.W. Stone Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
5. J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Jni, G. Sianos, G. Hellige, R.T. van Domburg, O.M. Hess, E. Boersma, B. Meier, S. Windecker, P.W. Serruys Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
6. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
7. B.J. Doyle, H.H. Ting, M.R. Bell, R.J. Lennon, V. Mathew, M. Singh, D.R. Holmes, C.S. Rihal Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 JACC Cardiovasc Interv 1 2008 202 209 (Pubitemid 351506552)
8. C. Medi, G. Montalescot, A. Budaj, K.A. Fox, J. Lpez-Sendn, G. FitzGerald, D.B. Brieger GRACE Investigators Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events) JACC Cardiovasc Interv 2 2009 26 33
9. I. Goldenberg, I. Subirana, V. Boyko, J. Vila, R. Elosua, G. Permanyer-Miralda, I. Ferreira-Gonzlez, M. Benderly, V. Guetta, S. Behar, J. Marrugat Relation between renal function and outcomes in patients with nonST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project Arch Intern Med 170 2010 888 895
10. Z. Motovska, P. Kala Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries Clin Ther 30 2008 2191 2202
11. Z. Motovska, J. Knot, P. Widimsky Stent thrombosisrisk assessment and prevention Cardiovasc Ther 28 2010 e92 e100
12. European Perspectives in Cardiology Centres of Excellence: the Cardiocentre Prague, Czech Republic Circulation 118 suppl 2008 f13 f18
13. L.A. Stevens, J. Coresh, C.H. Schmid, H.I. Feldman, M. Froissart, J. Kusek, J. Rossert, F. Van Lente, R.D. Bruce, Y.L. Zhang, T. Greene, A.S. Levey Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 2008 395 406 (Pubitemid 351273480)
14. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S266
15. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
16. L.A. Stevens, J. Coresh, T. Greene, A.S. Levey Assessing kidney functionmeasured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483 (Pubitemid 43855050)
17. O. Morel, S. El Ghannudi, L. Jesel, B. Radulescu, N. Meyer, M.L. Wiesel, S. Caillard, U. Campia, B. Moulin, C. Gachet, P. Ohlmann Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel J Am Coll Cardiol 57 2011 399 408
18. A.D. Michelson Methods for the measurement of platelet function Am J Cardiol 103 suppl 2009 20A 26A
19. Z. Motovska, P. Widimsky, R. Petr, D. Bilkova, I. Marinov, S. Simek, P. Kala Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness Int J Cardiol 144 2010 255 257
20. O.F. Laterza, C.P. Price, M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 2002 699 707 (Pubitemid 34439101)
21. J. Westhuyzen Cystatin C: a promising marker and predictor of impaired renal function Ann Clin Lab Sci 36 2006 387 394 (Pubitemid 44786685)
22. R. Bellomo, J.A. Kellum, C. Ronco Defining acute renal failure: physiological principles Intensive Care Med 30 2004 33 37 (Pubitemid 38147105)
23. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, L. Puklavec Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease Ren Fail 30 2008 181 186 (Pubitemid 351311483)
24. U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2007 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
25. F.G. Hage, R. Venkataraman, G.J. Zoghbi, G.J. Perry, A.M. DeMattos, A.E. Iskandrian The scope of coronary heart disease in patients with chronic kidney disease J Am Coll Cardiol 53 2009 2129 2140
26. P. Widimsky, I. Rychlik Renal disease and acute coronary syndrome Heart 96 2010 86 92
27. P. Muntner, L.L. Hamm, J.W. Kusek, J. Chen, P.K. Whelton, J. He The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
28. A.S. Sohal, A.S. Gangji, M.A. Crowther, D. Treleaven Uremic bleeding: Pathophysiology and clinical risk factors Thromb Res 118 2006 417 422 (Pubitemid 44067195)
29. K.P. Alexander, A.Y. Chen, M.T. Roe, L.K. Newby, C.M. Gibson, N.M. Allen-LaPointe, C. Pollack, W.B. Gibler, E.M. Ohman, E.D. Peterson CRUSADE Investigators Excess dosing of antiplatelet and antithrombin agents in the treatment of nonST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116 (Pubitemid 43016802)
30. M. Keltai, M. Tonelli, J.F. Mann, E. Sitkei, B.S. Lewis, S. Hawken, S.R. Mehta, S. Yusuf CURE Trial Investigators Renal function and outcomes in acute coronary syndrome: impact of clopidogrel Eur J Cardiovasc Prev Rehabil 14 2007 312 318 (Pubitemid 46650089)